Features
Indication prioritization with scored shortlists
Target and modality assessment (druggability, tractability, FTO)
Biomarker and patient selection from genomic/proteomic evidence
Clinical trial design (adaptive design, endpoint strategy, sample size)
Competitive intelligence synthesis
Regulatory gap analysis (IND, safety summaries)
MoA elucidation and target ID
Lead optimization and CMC support
TPP and valuation summaries
Reproducible code and validation protocols
No training on customer data
Supports any therapeutic area and modality
Discovery through commercialization support
Real-world data from millions of oncology patients globally
Flatiron Telescope AI platform for rapid oncology insights
LLM-based thematic analysis of clinical trial discussions
ML models predicting rapid progression in HR+/HER2- metastatic breast cancer
Real-world biomarker testing and outcomes studies
Point-of-care clinical decision support
Regulatory-grade real-world evidence generation
Cancer-specific data abstraction and curation
Custom study design and analytics services
Data quality assurance and validation processes
Multi-cancer type cohort identification
Publication support – over 2,000 peer-reviewed papers
49+ research acceptances at ASCO 2026
Integration with life sciences workflows
Professional services for research collaborations
Integrations
Electronic Health Record (EHR) systems
Laboratory information systems
Clinical trial management systems
Research data repositories
Genomic sequencing platforms
